NeuroOne Medical Technologies Corporation
NMTC
$0.712
-$0.0375-5.00%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 54.53% | 104.21% | 1.33% | -16.14% | -8.65% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 54.53% | 104.21% | 1.33% | -16.14% | -8.65% |
| Cost of Revenue | -21.50% | -26.56% | -26.02% | -4.03% | 18.83% |
| Gross Profit | 89.99% | 86.67% | 44.55% | -15.15% | -62.98% |
| SG&A Expenses | 1.20% | 4.51% | 14.08% | 5.53% | 10.34% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -26.02% | -23.46% | -0.15% | 8.68% | 23.35% |
| Operating Income | 49.20% | 49.96% | 0.57% | -20.06% | -37.17% |
| Income Before Tax | 48.43% | 46.64% | -3.87% | -19.84% | -36.36% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 48.43% | 46.64% | -3.87% | -19.84% | -36.36% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 48.43% | 46.64% | -3.87% | -19.84% | -36.36% |
| EBIT | 49.20% | 49.96% | 0.57% | -20.06% | -37.17% |
| EBITDA | 50.27% | 51.03% | 0.98% | -19.65% | -36.73% |
| EPS Basic | 61.09% | 61.58% | 29.76% | 18.54% | -1.93% |
| Normalized Basic EPS | 59.17% | 61.44% | 29.48% | 17.29% | -3.45% |
| EPS Diluted | 61.13% | 61.61% | 29.67% | 18.44% | -2.03% |
| Normalized Diluted EPS | 59.14% | 61.42% | 29.48% | 17.29% | -3.45% |
| Average Basic Shares Outstanding | 32.72% | 41.94% | 47.71% | 49.80% | 37.97% |
| Average Diluted Shares Outstanding | 32.77% | 41.99% | 47.71% | 49.80% | 37.97% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |